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Hepatitis C viral infection (HCV) is the most common
chronic blood borne viral infection in the world and in
the United States affects approximately 1.8% of the gen-
eral population. The prevalence of hepatitis C viral
infection (HCV) is 3-4 times higher among veterans
who use VA services than the general population rate of
1.8% and is estimated to be approximately 5 to 6%.
A national VA study found that over 75% of veterans
had some Substance Use Disorder. At the Portland
VAMC, 57.6% (n = 783) of veterans with HCV recently
s e e ni nt h eh e p a t o l o g yc l i n i cr e p o r t e dc o n s u m i n ga l c o -
hol in the past year and approximately 25% reported
heavy alcohol use (AUDIT C score of 4 or greater).
Alcohol use and HCV are thought to act synergisti-
cally to accelerate liver damage and cirrhosis. Several
studies show heavy alcohol consumption increases the
risk of fibrosis progression as well as the risk of end
stage liver disease and cirrhosis in HCV patients.
Among them Corrao and Arico (1998) found, among all
p a t i e n t sw h od on o td r i n ka l c o h o l ,H C V - i n f e c t e d
patients are 9.2 times more likely to develop liver cir-
rhosis than non-HCV-infected patients. They also found
that there is a dose-dependent relationship between life-
time daily alcohol intake, HCV infection, and risk of
developing cirrhosis. Compared to HCV patients who
do not drink, the risk of cirrhosis was three times higher
in HCV patients who drank 75 to 100 grams per day,
16 times higher in HCV patients who drank ≥175 grams
per day of alcohol than HCV patients who did not drink
and over 140 times higher than people who did not
have HCV or drink alcohol.
Effective treatments for alcohol use have not been stu-
died in patients chronically infected with HCV and cur-
rent FDA-approved medications for AUD can adversely
affect the liver and are generally not well tolerated. The
presentation will review current FDA -approved as well
as off-label use medication studies for Alcohol Use Dis-
orders and their utility for people who have hepatitis C
and co-morbid Alcohol Use Disorders. The various
treatment options will be discussed.
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